Showing results (21-30 of 439) with videos related to
Sort By:
Pageof 44
Oncology Research|January 1, 1996
Analysis of p21WAF1/CIP1 in primary bladder tumorsL Lacombe, I Orlow, D Silver, et al.Cancer Research|February 28, 2001
Intranuclear compartmentalization of cyclin E during the cell cycle: disruption of the nucleoplasm-nucleolar shuttling of cyclin E in bladder cancerG Juan, C Cordon-CardoJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after bacillus Calmette-Guérin therapy: correlation to clinical outcomeL Lacombe, G Dalbagni, Z F Zhang, et al.The Urologic Clinics of North America|March 4, 2000
Mutation of cell cycle regulators and their impact on superficial bladder cancerF Rabbani, C Cordon-CardoWorld Journal of Urology|January 1, 1997
Molecular and immunopathology studies of oncogenes and tumor-suppressor genes in bladder cancerC Cordon-Cardo, J SheinfeldLaboratory Investigation; a Journal of Technical Methods and Pathology|October 13, 2001
Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitationsA Hoos, C Cordon-CardoCancer Research|January 1, 1989
Blood group-related antigens in human kidney: modulation of Lewis determinants in renal cell carcinomaC Cordon-Cardo, V E Reuter, C L Finstad, et al.The Journal of Urology|April 1, 1994
Neuroendocrine differentiation in metastatic prostatic adenocarcinomaA G Aprikian, C Cordon-Cardo, W R Fair, et al.Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|March 1, 1993
Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancerG Dalbagni, J C Presti, V E Reuter, et al.Cancer Research|July 15, 1988
Blood group-related antigens in human urothelium: enhanced expression of precursor, LeX, and LeY determinants in urothelial carcinomaC Cordon-Cardo, V E Reuter, K O Lloyd, et al.Pageof 44